Parainfluenza virus 3 blocks antiviral mediators downstream of the interferon lambda receptor by modulating Stat1 phosphorylation

Journal of Virology

Volumn 90, Issue 6, 2016, Pages 2948-2958

  Eberle, Kirsten C ^a,b   McGill, Jodi L ^a,c   Reinhardt, Timothy A ^a   Sacco, Randy E ^a,b  

^a NATIONAL ANIMAL DISEASE CENTER   (United States)

^b IOWA STATE UNIVERSITY   (United States)

^c KANSAS STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; INTERFERON RECEPTOR; INTERLEUKIN 29; JANUS KINASE; LAMBDA INTERFERON RECEPTOR; STAT1 PROTEIN; STAT2 PROTEIN; UNCLASSIFIED DRUG; IL29 PROTEIN, HUMAN; INTERLEUKIN DERIVATIVE; STAT1 PROTEIN, HUMAN;

ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; HUMAN; HUMAN CELL; HUMAN PARAINFLUENZA VIRUS 3; INTRACELLULAR SIGNALING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; UPREGULATION; VIRUS IMMUNITY; ANIMAL; BOVINE PARAINFLUENZA VIRUS 3; CELL LINE; EPITHELIUM CELL; IMMUNE EVASION; IMMUNOLOGY; INNATE IMMUNITY; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; PROTEIN PROCESSING; VIROLOGY;

ANIMALS; CELL LINE; EPITHELIAL CELLS; HUMANS; IMMUNE EVASION; IMMUNITY, INNATE; INTERLEUKINS; PARAINFLUENZA VIRUS 3, BOVINE; PARAINFLUENZA VIRUS 3, HUMAN; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; STAT1 TRANSCRIPTION FACTOR;

EID: 84961164903     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02502-15     Document Type: Article

References (50)

1. Karron RA, Thumar B, Schappell E, Surman S, Murphy BR, Collins PL, Schmidt AC. 2012. Evaluation of two chimeric bovine-human parainfluenza virus type 3 vaccines in infants and young children. Vaccine 30:3975-3981. http://dx.doi.org/10.1016/j.vaccine.2011.12.022.
2. Karron RA, Wright PF, Hall SL, Makhene M, Thompson J, Burns BA, Tollefson S, Steinhoff MC, Wilson MH, Harris DO. 1995. A live attenuated bovine parainfluenza virus type 3 vaccine is safe, infectious, immunogenic, and phenotypically stable in infants and children. J Infect Dis 171:1107-1114. http://dx.doi.org/10.1093/infdis/171.5.1107.
3. Schmidt AC, McAuliffe JM, Huang A, Surman SR, Bailly JE, Elkins WR, Collins PL, Murphy BR, Skiadopoulos MH. 2000. Bovine parainfluenza virus type 3 (BPIV3) fusion and hemagglutinin-neuraminidase glycoproteins make an important contribution to the restricted replication of BPIV3 in primates. J Virol 74:8922-8929. http://dx.doi.org/10.1128/JVI.74.19.8922-8929.2000.
4. Henrickson KJ. 2003. Parainfluenza viruses. Clin Microbiol Rev 16:242-264. http://dx.doi.org/10.1128/CMR.16.2.242-264.2003.
5. Vareille M, Kieninger E, Edwards MR, Regamey N. 2011. The airway epithelium: soldier in the fight against respiratory viruses. Clin Microbiol Rev 24:210-229. http://dx.doi.org/10.1128/CMR.00014-10.
6. Sadler AJ, Williams BR. 2008. Interferon-inducible antiviral effectors. Nat Rev Immunol 8:559-568. http://dx.doi.org/10.1038/nri2314.
7. Andrejeva J, Childs KS, Young DF, Carlos TS, Stock N, Goodbourn S, Randall RE. 2004. The V proteins of paramyxoviruses bind the IFNinducible RNA helicase, mda-5, and inhibit its activation of the IFN-beta promoter. Proc Natl Acad Sci U S A 101:17264-17269. http://dx.doi.org/10.1073/pnas.0407639101.
8. Bossert B, Marozin S, Conzelmann KK. 2003. Nonstructural proteins NS1 and NS2 of bovine respiratory syncytial virus block activation of interferon regulatory factor 3. J Virol 77:8661-8668. http://dx.doi.org/10.1128/JVI.77.16.8661-8668.2003.
9. Childs K, Stock N, Ross C, Andrejeva J, Hilton L, Skinner M, Randall R, Goodbourn S. 2007. mda-5, but not RIG-I, is a common target for paramyxovirus V proteins. Virology 359:190-200. http://dx.doi.org/10.1016/j.virol.2006.09.023.
10. Childs KS, Andrejeva J, Randall RE, Goodbourn S. 2009. Mechanism of mda-5 Inhibition by paramyxovirus V proteins. J Virol 83:1465-1473. http://dx.doi.org/10.1128/JVI.01768-08.
11. Childs K, Randall R, Goodbourn S. 2012. Paramyxovirus V proteins interact with the RNA helicase LGP2 to inhibit RIG-I-dependent interferon induction. J Virol 86:3411-3421. http://dx.doi.org/10.1128/JVI.06405-11.
12. Elliott J, Lynch OT, Suessmuth Y, Qian P, Boyd CR, Burrows JF, Buick R, Stevenson NJ, Touzelet O, Gadina M, Power UF, Johnston JA. 2007. Respiratory syncytial virus NS1 protein degrades STAT2 by using the elongin-cullin E3 ligase. J Virol 81:3428-3436. http://dx.doi.org/10.1128/JVI.02303-06.
13. Kitagawa Y, Yamaguchi M, Zhou M, Nishio M, Itoh M, Gotoh B. 2013. Human parainfluenza virus type 2 V protein inhibits TRAF6-mediated ubiquitination of IRF7 to prevent TLR7-and TLR9-dependent interferon induction. J Virol 87:7966-7976. http://dx.doi.org/10.1128/JVI.03525-12.
14. Lu LL, Puri M, Horvath CM, Sen GC. 2008. Select paramyxoviral V proteins inhibit IRF3 activation by acting as alternative substrates for inhibitor of κB kinase ε (IKKe)/TBK1. J Biol Chem 283:14269-14276. http://dx.doi.org/10.1074/jbc.M710089200.
15. Ramaswamy M, Shi L, Varga SM, Barik S, Behlke MA, Look DC. 2006. Respiratory syncytial virus nonstructural protein 2 specifically inhibits type I interferon signal transduction. Virology 344:328-339. http://dx.doi.org/10.1016/j.virol.2005.09.009.
16. Yamaguchi M, Kitagawa Y, Zhou M, Itoh M, Gotoh B. 2014. An anti-interferon activity shared by paramyxovirus C proteins: inhibition of Toll-like receptor 7/9-dependent alpha interferon induction. FEBS Lett 588:28-34. http://dx.doi.org/10.1016/j.febslet.2013.11.015.
17. Kotenko SV, Gallagher G, Baurin VV, Lewis-Antes A, Shen M, Shah NK, Langer JA, Sheikh F, Dickensheets H, Donnelly RP. 2003. IFN-λs mediate antiviral protection through a distinct class II cytokine receptor complex. Nat Immunol 4:69-77. http://dx.doi.org/10.1038/ni875.
18. Sheppard P, Kindsvogel W, Xu W, Henderson K, Schlutsmeyer S, Whitmore TE, Kuestner R, Garrigues U, Birks C, Roraback J, Ostrander C, Dong D, Shin J, Presnell S, Fox B, Haldeman B, Cooper E, Taft D, Gilbert T, Grant FJ, Tackett M, Krivan W, McKnight G, Clegg C, Foster D, Klucher KM. 2003. IL-28, IL-29 and their class II cytokine receptor IL-28R. Nat Immunol 4:63-68. http://dx.doi.org/10.1038/ni873.
19. Miknis ZJ, Magracheva E, Li W, Zdanov A, Kotenko SV, Wlodawer A. 2010. Crystal structure of human interferon-λ1 in complex with its highaffinity receptor interferon-λR1. J Mol Biol 404:650-664. http://dx.doi.org/10.1016/j.jmb.2010.09.068.
20. Sommereyns C, Paul S, Staeheli P, Michiels T. 2008. IFN-lambda (IFN-λ) is expressed in a tissue-dependent fashion and primarily acts on epithelial cells in vivo. PLoS Pathog 4:e1000017. http://dx.doi.org/10.1371/journal.ppat.1000017.
21. Andrejeva J, Norsted H, Habjan M, Thiel V, Goodbourn S, Randall RE. 2013. ISG56/IFIT1 is primarily responsible for interferon-induced changes to patterns of parainfluenza virus type 5 transcription and protein synthesis. J Gen Virol 94:59-68. http://dx.doi.org/10.1099/vir.0.046797-0.
22. Emeny JM, Morgan MJ. 1979. Regulation of the interferon system: evidence that Vero cells have a genetic defect in interferon production. J Gen Virol 43:247-252. http://dx.doi.org/10.1099/0022-1317-43-1-247.
23. Osada N, Kohara A, Yamaji T, Hirayama N, Kasai F, Sekizuka T, Kuroda M, Hanada K. 2014. The genome landscape of the African green monkey kidney-derived Vero cell line. DNA Res 21:673-683. http://dx.doi.org/10.1093/dnares/dsu029.
24. Wathelet MG, Berr PM, Huez GA. 1992. Regulation of gene expression by cytokines and virus in human cells lacking the type-I interferon locus. Eur J Biochem 206:901-910. http://dx.doi.org/10.1111/j.1432-1033.1992.tb16999.x.
25. Ooi EL, Chan ST, Cho NE, Wilkins C, Woodward J, Li M, Kikkawa U, Tellinghuisen T, Gale M, Saito T. 2014. Novel antiviral host factor, TNK1, regulates IFN signaling through serine phosphorylation of STAT1. Proc Natl Acad Sci U S A 111:1909-1914. http://dx.doi.org/10.1073/pnas.1314268111.
26. Wen Z, Zhong Z, Darnell JE, Jr. 1995. Maximal activation of transcription by Statl and Stat3 requires both tyrosine and serine phosphorylation. Cell 82:241-250. http://dx.doi.org/10.1016/0092-8674(95)90311-9.
27. Zhang Y, Takami K, Lo MS, Huang G, Yu Q, Roswit WT, Holtzman MJ. 2005. Modification of the Stat1 SH2 domain broadly improves interferon efficacy in proportion to p300/CREB-binding protein coactivator recruitment. J Biol Chem 280:34306-34315. http://dx.doi.org/10.1074/jbc.M503263200.
28. Nollens HH, Wellehan JF, Saliki JT, Caseltine SL, Jensen ED, Van Bonn W, Venn-Watson S. 2008. Characterization of a parainfluenza virus isolated from a bottlenose dolphin (Tursiops truncatus). Vet Microbiol 128: 231-242. http://dx.doi.org/10.1016/j.vetmic.2007.10.005.
29. Eberle KC, Neill JD, Venn-Watson SK, McGill JL, Sacco RE. 2015. Novel Atlantic bottlenose dolphin parainfluenza virus TtPIV-1 clusters with bovine PIV-3 genotype B strains. Virus Genes 51:198-208. http://dx.doi.org/10.1007/s11262-015-1224-7.
30. -ΔΔCT method. Methods 25: 402-408. http://dx.doi.org/10.1006/meth.2001.1262.
31. Reed LJ, Muench J. 1938. A simple method of estimating fifty percent endpoints. Am J Hyg 27:493-497.
32. Horvath CM, Darnell JE. 1996. The antiviral state induced by alpha interferon and gamma interferon requires transcriptionally active Stat1 protein. J Virol 70:647-650.
33. Jensen K, Anderson JA, Glass EJ. 2014. Comparison of small interfering RNA (siRNA) delivery into bovine monocyte-derived macrophages by transfection and electroporation. Vet Immunol Immunopathol 158:224-232. http://dx.doi.org/10.1016/j.vetimm.2014.02.002.
34. Khaitov MR, Laza-Stanca V, Edwards MR, Walton RP, Rohde G, Contoli M, Papi A, Stanciu LA, Kotenko SV, Johnston SL. 2009. Respiratory virus induction of alpha-, beta-and lambda-interferons in bronchial epithelial cells and peripheral blood mononuclear cells. Allergy 64:375-386. http://dx.doi.org/10.1111/j.1398-9995.2008.01826.x.
35. Okabayashi T, Kojima T, Masaki T, Yokota S-I, Imaizumi T, Tsutsumi H, Himi T, Fujii N, Sawada N. 2011. Type-III interferon, not type-I, is the predominant interferon induced by respiratory viruses in nasal epithelial cells. Virus Res 160:360-366. http://dx.doi.org/10.1016/j.virusres.2011.07.011.
36. Spann KM, Tran K-C, Chi B, Rabin RL, Collins PL. 2004. Suppression of the induction of alpha, beta, and lambda interferons by the NS1 and NS2 proteins of human respiratory syncytial virus in human epithelial cells and macrophages. J Virol 78:4363-4369. http://dx.doi.org/10.1128/JVI.78.8.4363-4369.2004.
37. Wang J, Oberley-Deegan R, Wang S, Nikrad M, Funk CJ, Hartshorn KL, Mason RJ. 2009. Differentiated human alveolar type II cells secrete antiviral IL-29 (IFN-1) in response to influenza A infection. J Immunol 182:1296-1304. http://dx.doi.org/10.4049/jimmunol.182.3.1296.
38. Ank N, Iversen MB, Bartholdy C, Staeheli P, Hartmann R, Jensen UB, Dagnaes-Hansen F, Thomsen AR, Chen Z, Haugen H. 2008. An important role for type III interferon (IFN-λ/IL-28) in TLR-induced antiviral activity. J Immunol 180:2474-2485. http://dx.doi.org/10.4049/jimmunol.180.4.2474.
39. Wojciak JM, Martinez-Yamout MA, Dyson HJ, Wright PE. 2009. Structural basis for recruitment of CBP/p300 coactivators by STAT1 and STAT2 transactivation domains. EMBO J 28:948-958. http://dx.doi.org/10.1038/emboj.2009.30.
40. Zhang JJ, Zhao Y, Chait BT, Lathem WW, Ritzi M, Knippers R, Darnell JE. 1998. Ser727-dependent recruitment of MCM5 by Stat1α in IFN-γ-induced transcriptional activation. EMBO J 17:6963-6971. http://dx.doi.org/10.1093/emboj/17.23.6963.
41. Zhu X, Wen Z, Xu LZ, Darnell JE. 1997. Stat1 serine phosphorylation occurs independently of tyrosine phosphorylation and requires an activated Jak2 kinase. Mol Cell Biol 17:6618-6623. http://dx.doi.org/10.1128/MCB.17.11.6618.
42. Young DF, Didcock L, Goodbourn S, Randall RE. 2000. Paramyxoviridae use distinct virus-specific mechanisms to circumvent the interferon response. Virology 269:383-390. http://dx.doi.org/10.1006/viro.2000.0240.
43. Wu TR, Hong YK, Wang XD, Ling MY, Dragoi AM, Chung AS, Campbell AG, Han ZY, Feng GS, Chin YE. 2002. SHP-2 is a dualspecificity phosphatase involved in Stat1 dephosphorylation at both tyrosine and serine residues in nuclei. J Biol Chem 277:47572-47580. http://dx.doi.org/10.1074/jbc.M207536200.
44. Senft AP, Taylor RH, Lei W, Campbell SA, Tipper JL, Martinez MJ, Witt TL, Clay CC, Harrod KS. 2010. Respiratory syncytial virus impairs macrophage IFN-α/β-and IFN-γ-stimulated transcription by distinct mechanisms. Am J Respir Cell Mol Biol 42:404-414. http://dx.doi.org/10.1165/rcmb.2008-0229OC.
45. Ank N, West H, Bartholdy C, Eriksson K, Thomsen AR, Paludan SR. 2006. Lambda interferon (IFN-λ), a type III IFN, is induced by viruses and IFNs and displays potent antiviral activity against select virus infections in vivo. J. Virol. 80:4501-4509. http://dx.doi.org/10.1128/JVI.80.9.4501-4509.2006.
46. Yoon CH, Lee ES, Lim DS, Bae YS. 2009. PKR, a p53 target gene, plays a crucial role in the tumor-suppressor function of p53. Proc Natl Acad Sci U S A 106:7852-7857. http://dx.doi.org/10.1073/pnas.0812148106.
47. Liu MQ, Zhou DJ, Wang X, Zhou W, Ye L, Li JL, Wang YZ, Ho WZ. 2012. IFN-λ3 inhibits HIV infection of macrophages through the JAKSTAT pathway. PLoS ONE 7:e35902. http://dx.doi.org/10.1371/journal.pone.0035902.
48. Holzinger D, Jorns C, Stertz S, Boisson-Dupuis S, Thimme R, Weidmann M, Casanova JL, Haller O, Kochs G. 2007. Induction of MxA gene expression by influenza A virus requires type I or type III interferon signaling. J. Virol. 81:7776-7785. http://dx.doi.org/10.1128/JVI.00546-06.
49. Kuo TM, Hu CP, Chen YL, Hong MH, Jeng KS, Liang CC, Chen ML, Chang C. 2009. HBV replication is significantly reduced by IL-6. J Biomed Sci 16:41. http://dx.doi.org/10.1186/1423-0127-16-41.
50. Hinzey A, Alexander J, Corry J, Adams KM, Claggett AM, Traylor ZP, Davis IC, Webster Marketon JI. 2011. Respiratory syncytial virus represses glucocorticoid receptor-mediated gene activation. Endocrinology 152:483-494. http://dx.doi.org/10.1210/en.2010-0774.